BioArctic AB (publ) reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was SEK 1,289.61 million compared to SEK 29.64 million a year ago. Net income was SEK 1,021.47 million compared to net loss of SEK 57.56 million a year ago. Basic earnings per share from continuing operations was SEK 11.55 compared to basic loss per share from continuing operations of SEK 0.65 a year ago. Diluted earnings per share from continuing operations was SEK 11.53 compared to diluted loss per share from continuing operations of SEK 0.65 a year ago.
